CrossRef KCMF1 promotes MASLD progression via K48-linked ubiquitination and degradation of AMPK Min Tang, Yunqin Ma, Jiaqi Wang, Han Cao, Shuangshuang Yao, Xiaohui Wei, Yijiong Tan, Hua Yang, Yi Lin, Bin Hu, Yang Yu, Jiaying Yang, Yufan Wang, Xingdong Zheng, Xiaofang Tang, Fang Liu, Yongde Peng, Nengguang Fan Metabolism .2026

drug pair in the treatment of non-alcoholic fatty liver disease Huafeng Chen, Shengzhe Yan, Qianru Xiang, Jiamin Liang, Xuejian Deng, Wanqin He, Yanzhen Cheng, Li Yang BMC Complementary Medicine and Therapies.2024;[Epub] CrossRef Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism Xu Dong, Yu-Ting Xiong, Tingting He, Congyang Zheng, Junjie Li, Yingjie Zhuang, Yingjie Xu, Ye Xiu, Zhixin Wu, Xiaomei Zhao, Xiaohe Xiao, Zhaofang Bai, Lili Gao Genes & Nutrition.2024;[Epub] CrossRef Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-B pathway Junyi Chen, Shuzhan Yang, Hanxia Luo, Xinliang Fu, Wanyan Li, Bingxin Li, Cheng Fu, Feiyue Chen, Danning Xu, Nan Cao International Immunopharmacology.2024
doi:10.1111/dom.15272 6
Future research is warranted to explore the prolonged implications of GLP-1 RAs on oncogenic risk
Some of this can be attributed to changing habits that support better health and weight loss, but some shifts may be the result of the negative side-effects from the GLP-1s, including muscle loss and digestive issues
They were particularly focused on its potential to accelerate gastric emptying